{{Drugbox
| verifiedrevid = 399726521

<!--Combo data-->
| type = combo
| component1 = Ampicillin
| class1 = Moderate-spectrum [[penicillin]]
| component2 = Flucloxacillin
| class2 = [[Antistaphylococcal penicillin]]

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration = Oral, [[intravenous therapy|intravenous]]

<!--Identifiers-->
| CAS_number =  
| ATC_prefix = J01
| ATC_suffix = CR50
| PubChem =  
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 21106281

<!--Chemical data-->
| smiles = O=C(O)[C@@H]2N3C(=O)[C@@H](NC(=O)[C@H](N)c1ccccc1)[C@H]3SC2(C)C.Fc1cccc(Cl)c1c2noc(C)c2C(=O)N[C@@H]3C(=O)N4[C@@H](C(O)=O)C(C)(C)S[C@H]34
| InChI = 1/C19H17ClFN3O5S.C16H19N3O4S/c1-7-10(12(23-29-7)11-8(20)5-4-6-9(11)21)15(25)22-13-16(26)24-14(18(27)28)19(2,3)30-17(13)24;1-16(2)11(15(22)23)19-13(21)10(14(19)24-16)18-12(20)9(17)8-6-4-3-5-7-8/h4-6,13-14,17H,1-3H3,(H,22,25)(H,27,28);3-7,9-11,14H,17H2,1-2H3,(H,18,20)(H,22,23)/t13-,14+,17-;9-,10-,11+,14-/m11/s1
| InChIKey = MRHKOEQOYWPVKY-TWZKVBNYBV
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C19H17ClFN3O5S.C16H19N3O4S/c1-7-10(12(23-29-7)11-8(20)5-4-6-9(11)21)15(25)22-13-16(26)24-14(18(27)28)19(2,3)30-17(13)24;1-16(2)11(15(22)23)19-13(21)10(14(19)24-16)18-12(20)9(17)8-6-4-3-5-7-8/h4-6,13-14,17H,1-3H3,(H,22,25)(H,27,28);3-7,9-11,14H,17H2,1-2H3,(H,18,20)(H,22,23)/t13-,14+,17-;9-,10-,11+,14-/m11/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = MRHKOEQOYWPVKY-TWZKVBNYSA-N
}}
'''[[Ampicillin]]/[[flucloxacillin]]''' ([[International Nonproprietary Name|INNs]]) or '''co-fluampicil''' ([[British Approved Name|BAN]]) is a combination drug of two [[&beta;-lactam antibiotic]]s, sold under the trade name '''Magnapen'''.

==Indication==
Ampicillin is a moderate spectrum penicillin antibiotic with good cover against [[group A streptococcal infection]] whilst flucloxacillin is a narrow spectrum antibiotic with cover against ''[[Staphylococcus aureus]]''. The combination covers the two most likely bacteria in [[cellulitis]] infections in the arm or leg.

==Formulations==
Capsules contain 250&nbsp;[[milligram|mg]] of each component, the syrup 125/125&nbsp;mg per spoon, and the powder for reconstruction for [[intravenous]] injection 250/250&nbsp;mg.

==Side effects and contraindications==
As per the individual components with stomach or bowel upset from the flucloxacillin being the most common. Both parts are members of the [[penicillin]] family of antibiotics, and therefore should not be taken by patients allergic to penicillin. See [[flucloxacillin]] for additional contraindications.

==References==
*[[British National Formulary]] '50' September 2005

{{Cell wall disruptive antibiotics}}

{{DEFAULTSORT:Ampicillin flucloxacillin}}
[[Category:Combination antibiotics]]
[[Category:Beta-lactam antibiotics]]


{{antiinfective-drug-stub}}